Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized mechanistic study of ticagrelor versus clopidogrel/placebo with aspirin in STEMI treated by primary PCI
2014-001277-14Phase 2Unknown
- Sponsor
- Royal Papworth Hospital
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in myocardial infarction (MI) comparing Brilique + aspirin, clopidogrel + aspirin and placebo + aspirin (3 arms). Primary endpoint: Index of myocardial resistance. Status: unknown.
02
Drugs
ticagrelorclopidogrelaspirin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2014-001277-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001277-14.